Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of AZD9977 and Dapagliflozin Formulations
NCT04798222Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of balcinrenone in heart failure (HF) (8 arms), sponsored by AstraZeneca. Primary endpoints: Area under plasma concentration time curve from zero to infinity, Area under the plasma concentration time curve from zero to the last quantifiable concentration and 2 more. Started Jun 2021; status: completed.
02
Drugs
balcinrenone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT04798222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04798222.